2,685 results on '"Elephantiasis, Filarial"'
Search Results
2. Integrated Mapping of Skin-presenting Neglected Tropical Diseases in Liberia
3. Moxidectin for LF, Cote d'Ivoire (DOLF)
4. East New Britain Province Monitoring & Evaluation (ENBP M&E)
5. Development of AWZ1066S, a Small Molecule Anti-Wolbachia Candidate Macrofilaricide Drug (AWOL)
6. Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin
7. Lymphatic Filariasis (LF) in Ivory Coast
8. Adjunctive Ivermectin Mass Drug Administration for Malaria Control (MATAMAL)
9. Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia (DOLF-LIBERIA)
10. A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in India (LeDoxy-India)
11. A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali (LeDoxy-Mali)
12. A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in Sri Lanka (LeDoxy-SL)
13. Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis
14. Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis
15. Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji (FIT)
16. Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis (DOLF-Indo)
17. Spontaneous Antigenemia in Loiasis
18. Twice Yearly Treatment for the Control of LF
19. Optimization of MDA With Existing Drug Regimens for LF: Monitoring Efficacy of Ongoing Treatment Programs in PNG (MDA)
20. Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE)
21. PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs )
22. Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )
23. Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study (RIMDAMAL)
24. Prevalence of LF Infection in Districts Not Included in LF Control Activities
25. Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa
26. Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast)
27. Effect of Albendazole Dose on Clearance of Filarial Worms
28. Effect of Albendazole Dose on Clearance of Filarial Worms
29. Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without Lymphatic Filariasis
30. Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali
31. Effect of Albendazole Dose on Treatment of Lymphatic Filariasis
32. Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in Malawi (FED)
33. Interruption of lymphatic filariasis transmission in Manaus, a former focus of Wuchereria bancrofti in the Western Brazilian Amazon.
34. The effectiveness of albendazole against hookworm infections and the impact of bi-annual treatment on anaemia and body mass index of school children in the Kpandai district of northern Ghana.
35. Identification and characterization of a novel nematode pan allergen (NPA) from Wuchereria bancrofti and their potential role in human filarial tropical pulmonary eosinophilia (TPE).
36. Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis (AZIVAL2)
37. Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern India
38. Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial
39. Unilateral Lower Extremity Elephantiasis
40. Prevalence and management of filarial lymphoedema and its associated factors in Lindi district, Tanzania: A community‐based cross‐sectional study
41. Disease Burden Estimation of Lymphatic Filariasis in an Endemic Area
42. Canine filaria species in selected lymphatic filariasis endemic and non-endemic areas in Sri Lanka
43. Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis Elimination (AZIVAL)
44. Integration of services for Neglected Tropical Diseases and mental health in Nigeria: development of a practical model informed by international recommendations, contextual factors and service-user perspectives.
45. Mosquito-borne diseases in India over the past 50 years and their Global Public Health Implications: A Systematic Review.
46. Detection of Wuchereria bancrofti in human blood samples and mosquitoes in Matayos, Busia County-Kenya.
47. Semiannual Treatment of Albendazole Alone is Efficacious for Treatment of Lymphatic Filariasis: A Randomized Open-label Trial in Cote d’Ivoire
48. Impact of Annual versus Semiannual Mass Drug Administration with Ivermectin and Albendazole on Helminth Infections in Southeastern Liberia
49. Research for Elimination of Lymphatic Filariasis (ICIDR)
50. Interaction Between HIV and Lymphatic Filariasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.